Source: Annual Congress 2005 - Pulmonary thromboembolic disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Ribas, F. Mannucci, M. Gherardi, G. Palmiero, G. Bardi, M. Digiorgio, N. Carpenè, A. Palla (Pisa, Italy). 1 year clinical follow-up of patients affected by acute pulmonary embolism (PE). Eur Respir J 2005; 26: Suppl. 49, 1821

Member's Comments

No comment yet.

Related content which might interest you: Results of dynamic follow-up of patients after idiopathic pulmonary embolism (PE) Source: Eur Respir J 2006; 28: Suppl. 50, 47s Year: 2006 Analysis of long-term survival of patients diagnosed of pulmonary embolism (PE) Source: Annual Congress 2006 - Pulmonary embolism Year: 2006 A risk score of adverse short-term clinical outcomes in patients with acute pulmonary embolism (PE) Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005 Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)? Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Evolution of pulmonary embolism: 1 year of follow-up Source: Eur Respir J 2006; 28: Suppl. 50, 401s Year: 2006 Internal validation of a model to predict the risk of short-term (10 days) adverse outcomes in patients with pulmonary embolism (PE) Source: Annual Congress 2006 - Pulmonary embolism Year: 2006 A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development Source: Eur Respir J 2003; 22: Suppl. 45, 221s Year: 2003 Recurrence and bleeding in the extended treatment of patients with pulmonary embolism (PE) and cancer Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018 Different mortality, recurrence and bleeding between cancer and non cancer patients with pulmonary embolism (PE): 1 year follow-up. Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 The controlled study of a 6-month course of acute pulmonary embolism in patients with syncope at admission Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005 Results of a dedicated service for pulmonary embolism (PE): 1 year follow up Source: Eur Respir J 2004; 24: Suppl. 48, 560s Year: 2004 Accuracy of pre-operative specimen level prediction in chronic thromboembolic pulmonary hypertension (CTEPH) patients undergoing pulmonary thromboendarterectomy (PTE) Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 The use of pulmonary embolism severity index (PESI) score in identifying patients suitable for ambulatory treatment or early hospital discharge following diagnosis of pulmonary embolism Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension (CTEPH) as early follow-up treatment after pulmonary endarterectomy (PEA) – a prospective cohort study Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Results from a national pulmonary embolism (PE) registry: clinical characteristics of 751 acute pe (ape) patients Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease Year: 2009 The potential benefits of outpatient investigations of suspected pulmonary embolism (PE) Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011 The effectiveness of plasmaferesis in patients with relapsing and progressing course of pulmonary sarcoidosis (5 years follow-up) Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Risk factors and clinical significance of residual perfusion defects after symptomatic pulmonary embolism (PE) Source: Annual Congress 2007 - Acute and chronic pulmonary embolism Year: 2007 Disease severity for enrollment criteria of patients with idiopathic pulmonary fibrosis (IPF) in clinical trial: evaluation of time to first episode of acute exacerbation (TTA) Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 The use test valsalva manoevre (VM) in diagnosis pulmonary hypertension (PH) for early rehabilitation of patients with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 72s Year: 2006